TORONTO, Sept. 19, 2017 (GLOBE NEWSWIRE) -- TerrAscend Corp. (CSE:TER)
(“TerrAscend” or the “Company”) announces that it has determined not to proceed with the
placement of the convertible debenture that was previously announced on August 23, 2017.
About TerrAscend
TerrAscend is a vertically-integrated Canadian cannabis company that strives to create and deliver quality products
and services that meet the evolving needs of the cannabis market. The Company provides support to patients through its wholly-owned
subsidiaries, Solace Health Inc. (“Solace Health”), a licensed producer of medical cannabis under
the Access to Cannabis for Medical Purposes Regulations, Terra Health Network Inc. (“Terra Health”),
a clinical support program and education platform led by health care professionals, and Solace Rx Inc.
(“SolaceRx”), a drug preparation premises for non-cannabis formulations. Please visit www.TerrAscend.com for more information about the Company.
Forward-looking statements
This news release contains "forward-looking information" within the meaning of applicable securities laws.
Although TerrAscend believes in light of the experience of its officers and directors, current conditions and expected future
developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking
information are reasonable, undue reliance should not be placed on them because TerrAscend can give no assurance that they will
prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and
developments may differ materially from those contemplated by these statements. The statements in this press release are made as of
the date of this release. TerrAscend undertakes no obligation to comment on analyses, expectations or statements made by
third-parties in respect of TerrAscend, its securities, or financial or operating results (as applicable). TerrAscend disclaims any
intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or
results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or
accuracy of the content of this news release.
For more information:
Ari Unterman
Investor Relations
1-855-TERRA-95 x100
aunterman@terrascend.com
Basem Hanna
President and CEO
1-855 TERRA 95
bhanna@terrascend.com
